ScreenerHero

CAICAI International, Inc.

NYSE · US · Industrials · Biotechnology · carislifesciences.com
26.27USD+15.42%Mkt Cap: 7.42B $P/E: 2.74

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare usin…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap7.42B $
Enterprise Value6.61B $
Revenue (TTM)989.60M $
Gross Profit539.17M $
Net Income (TTM)-68.09M $
Revenue/Share3.492 USD
Last Price26.27 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.8K
CountryUS
SectorIndustrials
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)2.74
P/E (Forward)65.05
PEG—
EV/EBITDA37.96
EV/Revenue6.67
P/S7.02
P/B11.74
EPS (TTM)10.34
EPS (Forward)0.38
52W Range
14.1943% of range42.50
52W High42.50 USD
52W Low14.19 USD
Profitability
Gross Margin66.40%
Oper. Margin10.21%
EBITDA Margin17.58%
Profit Margin-8.38%
ROE-11.79%
ROA-6.05%
Growth
Revenue Growth45.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF83.16M $
CapEx (TTM)16.26M $
FCF Margin6.39%
FCF Yield0.85%
Net Debt-340.71M $
Net Debt/EBITDA-1.96
Balance Sheet
Debt/Equity0.74
Current Ratio5.53
Quick Ratio4.75
Book Value/Sh2.094 USD
Cash/Share2.807 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)27.00 USD
Upside (mean)+2.8%
Target Range22.00 USD – 36.00 USD
$22.00+2.8% to mean$36.00
# Analysts12
Ownership
Shares Out.282.60M
Float135.51M
Insiders48.56%
Institutions55.65%
Short Interest
Short Ratio4.1d
Short % Float12.82%
Short % Out.5.22%
Shares Short14.76M
Short (prev mo.)14.18M
Technical
SMA 5018.23 (+44.1%)
SMA 20020.96 (+25.3%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)4.53M
Avg Vol (10d)5.12M
Technical Indicators
RSI (14)79.0
MACD1.8661
MACD Signal1.2476
MACD Hist.+0.6185
BB Upper26.53 USD
BB Middle19.24 USD
BB Lower11.95 USD
BB Width75.78%
ATR (14)1.293 USD
Vol Ratio (20d)1.31x